These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
204 related articles for article (PubMed ID: 23864783)
1. Transcatheter arterial chemoembolization followed by immediate radiofrequency ablation for large solitary hepatocellular carcinomas. Wang ZJ; Wang MQ; Duan F; Song P; Liu FY; Chang ZF; Wang Y; Yan JY; Li K World J Gastroenterol; 2013 Jul; 19(26):4192-9. PubMed ID: 23864783 [TBL] [Abstract][Full Text] [Related]
2. Combination transarterial chemoembolization and radiofrequency ablation therapy for early hepatocellular carcinoma. Song MJ; Bae SH; Lee JS; Lee SW; Song DS; You CR; Choi JY; Yoon SK Korean J Intern Med; 2016 Mar; 31(2):242-52. PubMed ID: 26874512 [TBL] [Abstract][Full Text] [Related]
3. Short-term interval combined chemoembolization and radiofrequency ablation for hepatocellular carcinoma. Choe WH; Kim YJ; Park HS; Park SW; Kim JH; Kwon SY World J Gastroenterol; 2014 Sep; 20(35):12588-94. PubMed ID: 25253962 [TBL] [Abstract][Full Text] [Related]
4. Combined transcatheter arterial chemoembolization and radiofrequency ablation in single-session for solitary hepatocellular carcinoma larger than 7 cm. Yan JY; Zhang JL; Wang MQ; Yuan K; Bai YH; Wang Y; Xin HN; Wang ZJ; Liu FY; Duan F; Fu JX Asia Pac J Clin Oncol; 2018 Aug; 14(4):300-309. PubMed ID: 29124894 [TBL] [Abstract][Full Text] [Related]
5. Transcatheter Arterial Chemoembolization Combined with Simultaneous Computed Tomography-guided Radiofrequency Ablation for Large Hepatocellular Carcinomas. Zuo TY; Liu FY; Wang MQ; Chen XX Chin Med J (Engl); 2017 Nov; 130(22):2666-2673. PubMed ID: 29133753 [TBL] [Abstract][Full Text] [Related]
6. Radiofrequency ablation versus transarterial chemoembolization for unresectable solitary hepatocellular carcinomas sized 5-8 cm. Dai WC; Cheung TT; Chok KS; Chan AC; Sharr WW; Tsang SH; Yuen WK; Chan SC; Fan ST; Lo CM; Poon RT HPB (Oxford); 2015 Mar; 17(3):226-31. PubMed ID: 25284590 [TBL] [Abstract][Full Text] [Related]
7. Long-term outcome of transcatheter arterial chemoembolization after radiofrequency ablation as a combined therapy for Chinese patients with hepatocellular carcinoma. Xu RC; Liu HC; Li JL; Li K; Ou SY; Yu ZY; Kong Y; Ma GA; Shao WS Curr Med Res Opin; 2015 Aug; 31(8):1553-60. PubMed ID: 26067770 [TBL] [Abstract][Full Text] [Related]
8. Transcatheter arterial chemoembolization combined with radiofrequency ablation delays tumor progression and prolongs overall survival in patients with intermediate (BCLC B) hepatocellular carcinoma. Yin X; Zhang L; Wang YH; Zhang BH; Gan YH; Ge NL; Chen Y; Li LX; Ren ZG BMC Cancer; 2014 Nov; 14():849. PubMed ID: 25409554 [TBL] [Abstract][Full Text] [Related]
9. Transarterial Chemoembolization Followed by Radiofrequency Ablation for Hepatocellular Carcinoma: Impact of the Time Interval between the Two Treatments on Outcome. Liu D; Liu M; Su L; Wang Y; Zhang X; Long H; Kuang M; Xie X; Lin M J Vasc Interv Radiol; 2019 Dec; 30(12):1879-1886. PubMed ID: 31669087 [TBL] [Abstract][Full Text] [Related]
10. Comparison of Angio-CT and cone-beam CT-guided immediate radiofrequency ablation after transcatheter arterial chemoembolization for large hepatocellular carcinoma. Yuan H; Li X; Tian X; Ji K; Liu F Abdom Radiol (NY); 2020 Aug; 45(8):2585-2592. PubMed ID: 32107583 [TBL] [Abstract][Full Text] [Related]
11. Radiofrequency ablation combined with chemoembolization for intermediate-sized (3-5 cm) hepatocellular carcinomas under dual guidance of biplane fluoroscopy and ultrasonography. Min JH; Lee MW; Cha DI; Jeon YH; Shin SW; Cho SK; Rhim H; Lim HK Korean J Radiol; 2013; 14(2):248-58. PubMed ID: 23483753 [TBL] [Abstract][Full Text] [Related]
12. Meta-analysis of transcatheter arterial chemoembolization plus radiofrequency ablation versus transcatheter arterial chemoembolization alone for hepatocellular carcinoma. Yang DJ; Luo KL; Liu H; Cai B; Tao GQ; Su XF; Hou XJ; Ye F; Li XY; Tian ZQ Oncotarget; 2017 Jan; 8(2):2960-2970. PubMed ID: 27936465 [TBL] [Abstract][Full Text] [Related]
13. Modified cisplatin-based transcatheter arterial chemoembolization for large hepatocellular carcinoma: multivariate analysis of predictive factors for tumor response and survival in a 163-patient cohort. Yoon HM; Kim JH; Kim EJ; Gwon DI; Ko GY; Ko HK J Vasc Interv Radiol; 2013 Nov; 24(11):1639-46. PubMed ID: 23962438 [TBL] [Abstract][Full Text] [Related]
14. Treatment of Small Hepatocellular Carcinoma (≤2 cm) in the Caudate Lobe with Sequential Transcatheter Arterial Chemoembolization and Radiofrequency Ablation. Hyun D; Cho SK; Shin SW; Rhim H; Koh KC; Paik SW Cardiovasc Intervent Radiol; 2016 Jul; 39(7):1015-22. PubMed ID: 26975761 [TBL] [Abstract][Full Text] [Related]
15. Single-step multimodal locoregional treatment for unresectable hepatocellular carcinoma: balloon-occluded percutaneous radiofrequency thermal ablation (BO-RFA) plus transcatheter arterial chemoembolization (TACE). Iezzi R; Cesario V; Siciliani L; Campanale M; De Gaetano AM; Siciliano M; Agnes S; Giuliante F; Grieco A; Pompili M; Rapaccini GL; Gasbarrini A; Bonomo L; Radiol Med; 2013 Jun; 118(4):555-69. PubMed ID: 23358819 [TBL] [Abstract][Full Text] [Related]
16. Radiofrequency ablation with or without transcatheter arterial chemoembolization in the treatment of hepatocellular carcinoma: a prospective randomized trial. Peng ZW; Zhang YJ; Chen MS; Xu L; Liang HH; Lin XJ; Guo RP; Zhang YQ; Lau WY J Clin Oncol; 2013 Feb; 31(4):426-32. PubMed ID: 23269991 [TBL] [Abstract][Full Text] [Related]
17. Analysis on efficacy and safety of TACE in combination with RFA and MWA in the treatment of middle and large primary hepatic carcinoma. Yuan P; Zhang Z; Kuai J J BUON; 2019; 24(1):163-170. PubMed ID: 30941966 [TBL] [Abstract][Full Text] [Related]
18. Meta-analysis of radiofrequency ablation in combination with transarterial chemoembolization for hepatocellular carcinoma. Ni JY; Liu SS; Xu LF; Sun HL; Chen YT World J Gastroenterol; 2013 Jun; 19(24):3872-82. PubMed ID: 23840128 [TBL] [Abstract][Full Text] [Related]
19. Single-session combined therapy with chemoembolization and radiofrequency ablation in hepatocellular carcinoma less than or equal to 5 cm: a preliminary study. Kang SG; Yoon CJ; Jeong SH; Kim JW; Lee SH; Lee KH; Kim YH J Vasc Interv Radiol; 2009 Dec; 20(12):1570-7. PubMed ID: 19879777 [TBL] [Abstract][Full Text] [Related]
20. The role of adjuvant transcatheter arterial chemoembolization following repeated curative resection/ablation for hepatocellular carcinoma with early recurrence: a propensity score matching analysis. Huang K; Qian T; Chen W; Lao M; Li H; Lin WC; Chen BW; Bai X; Gao S; Ma T; Liang T BMC Cancer; 2024 May; 24(1):620. PubMed ID: 38773564 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]